Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14238
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Van Heirstraeten, Liesbet | - |
dc.contributor.author | Coenen, Samuel | - |
dc.contributor.author | Lammens, Christine | - |
dc.contributor.author | HENS, Niel | - |
dc.contributor.author | Goossens, Herman | - |
dc.contributor.author | Malhotra-Kumar, Surbhi | - |
dc.date.accessioned | 2012-10-05T09:13:44Z | - |
dc.date.available | 2012-10-05T09:13:44Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518 | - |
dc.identifier.issn | 1080-6040 | - |
dc.identifier.uri | http://hdl.handle.net/1942/14238 | - |
dc.description.abstract | In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs. | - |
dc.description.sponsorship | This study was partly funded by the Belgian Antibiotic Policy Coordination Committee. | - |
dc.language.iso | en | - |
dc.publisher | CENTERS DISEASE CONTROL | - |
dc.subject.other | Immunology; Infectious Diseases | - |
dc.title | Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1518 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | 1515 | - |
dc.identifier.volume | 18 | - |
local.format.pages | 4 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Malhotra-Kumar, S (reprint author),[Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, B-2020 Antwerp, Belgium. [Hens, Niel] Univ Hasselt, Hasselt, Belgium. surbhi.malhotra@ua.ac.be | - |
local.publisher.place | ATLANTA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.3201/eid1809.120049 | - |
dc.identifier.isi | 000307989700024 | - |
item.accessRights | Open Access | - |
item.fullcitation | Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; HENS, Niel; Goossens, Herman & Malhotra-Kumar, Surbhi (2012) Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium. In: EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518. | - |
item.contributor | Van Heirstraeten, Liesbet | - |
item.contributor | Coenen, Samuel | - |
item.contributor | Lammens, Christine | - |
item.contributor | HENS, Niel | - |
item.contributor | Goossens, Herman | - |
item.contributor | Malhotra-Kumar, Surbhi | - |
item.fulltext | With Fulltext | - |
item.validation | ecoom 2013 | - |
crisitem.journal.issn | 1080-6040 | - |
crisitem.journal.eissn | 1080-6059 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Antimicrobial drug use and macrolide-resistant streptococcus pyogenes, Belgium.pdf | Published version | 312.48 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
24
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
29
checked on Apr 22, 2024
Page view(s)
64
checked on Sep 7, 2022
Download(s)
104
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.